The puretech story, where Roche considered the exosomes from mere milk compelling enough to participate in a $1bil collaboration, underpin that there is real potential legs to this biotech genre
imho EX1 may surprise themselves - yes partnering would bring a capital/ ‘ market cap’ sugar hit... but just quietly i would rather this stay under the radar to be able to quietly accumulate whilst each product comes to market. I think the results will surprise even the company management
The puretech story, where Roche considered the exosomes from...
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
